Hoth Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Hoth Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • Hoth Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.13M, a 2.18% decline year-over-year.
  • Hoth Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.51M, a 22% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.85M, a 31% increase from 2022.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.4M, a 20.6% increase from 2021.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.3M, a 98.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.85M +$3.53M +31% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$11.4M +$2.94M +20.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$14.3M -$7.12M -98.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$7.2M +$507K +6.58% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$7.7M -$5.21M -209% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$2.5M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.